Targeting GRIA3 in Breast Cancer: Cuproptosis-Related Genes Unveil Immune Dysregulation and Prognostic Stratification
The Tohoku Journal of Experimental Medicine · 2026 · 269 (2) · 249-266
DOI: 10.1620/tjem.2026.j032 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Tohoku Journal of Experimental Medicine, 2026. Verfasst von Fuming Yang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integrated Traditional Chinese and Western Medicine, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University. Hauptthemen laut MEDLINE: Cuproptosis, Breast Neoplasms. Die Arbeit nennt 28 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Integrated Traditional Chinese and Western Medicine, Yantai Yuhuangding Hospital Affiliated to Medical College of Qingdao University.
- Jiangsu Key Laboratory of Molecular Medicine, Medical School of Nanjing University.
Zitieren
APA
Yang, F., & Wei, J. (2026). Targeting GRIA3 in Breast Cancer: Cuproptosis-Related Genes Unveil Immune Dysregulation and Prognostic Stratification. The Tohoku Journal of Experimental Medicine, 269(2), 249-266. https://doi.org/10.1620/tjem.2026.j032
Vancouver
Yang F, Wei J. Targeting GRIA3 in Breast Cancer: Cuproptosis-Related Genes Unveil Immune Dysregulation and Prognostic Stratification. The Tohoku Journal of Experimental Medicine. 2026;269(2):249-266. doi:10.1620/tjem.2026.j032
BibTeX
@article{Yang2026,
author = {Yang, Fuming and Wei, Jiwu},
title = {Targeting GRIA3 in Breast Cancer: Cuproptosis-Related Genes Unveil Immune Dysregulation and Prognostic Stratification},
journal = {The Tohoku Journal of Experimental Medicine},
year = {2026},
volume = {269},
number = {2},
pages = {249--266},
doi = {10.1620/tjem.2026.j032}
}
EUVIMED